Annovis Bio Inc company info

What does Annovis Bio Inc do?
Annovis Bio (NYSEAMERICAN:ANVS) specializes in developing novel therapies aimed at treating neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. This pioneering venture focuses on addressing the underlying causes of these debilitating conditions, striving to halt or reverse the progression of symptoms. Annovis Bio’s projects are centered on its innovative lead compound, aiming to improve cognitive and motor functions in affected individuals. Through rigorous research and development, the company’s objective is to offer groundbreaking treatments that can significantly enhance the quality of life for patients grappling with these challenging disorders, marking a substantial step forward in neurodegenerative disease management.
Annovis Bio Inc company media
Company Snapshot

Is Annovis Bio Inc a public or private company?

key
Ownership
Public

How many people does Annovis Bio Inc employ?

people
Employees
8

What sector is Annovis Bio Inc in?

pie chart
Sector
Health Care

Where is the head office for Annovis Bio Inc?

location pin
Head Office
Malvern, United States

What year was Annovis Bio Inc founded?

founded flag
Year Founded
2008
What does Annovis Bio Inc specialise in?
/Neurodegenerative Diseases /Therapeutic Drugs /Alzheimer's Treatment /Parkinson's Treatment /Drug Development /Clinical Trials

What are the products and/or services of Annovis Bio Inc?

Overview of Annovis Bio Inc offerings
Development of ANVS401 for neurodegenerative diseases, focusing on Alzheimer's and Parkinson's.
Research into bispecific antibody technology for targeting neurodegenerative disease pathways.
Investigation of ANVS405 for the protection of nerve cells in neurodegenerative conditions.
Exploration of treatments aimed at reducing neuroinflammation as a common symptom of neurodegenerative diseases.
Involvement in early-stage discovery of biomarkers for neurodegenerative diseases to improve diagnosis and treatment.
Contribution to a collaborative project focused on understanding the role of toxic proteins in the progression of neurodegenerative diseases.

Who is in the executive team of Annovis Bio Inc?

Annovis Bio Inc leadership team
  • Dr. Maria L. Maccecchini Ph.D.
    Dr. Maria L. Maccecchini Ph.D.
    Founder, CEO, President & Executive Director
  • Mr. Henry  Hagopian III, M.B.A.
    Mr. Henry Hagopian III, M.B.A.
    Chief Financial Officer
  • Dr. Cheng  Fang Ph.D.
    Dr. Cheng Fang Ph.D.
    Senior Vice President of Research & Development
  • Ms. Eve M. Damiano M.S., RAC
    Ms. Eve M. Damiano M.S., RAC
    Senior Vice President of Regulatory Operations
  • Ms. Melissa  Gaines
    Ms. Melissa Gaines
    Senior Vice President of Clinical Operations